Conference Coverage
Latest Content
Dec 07, 2025 | News
EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
Dec 07, 2025
Making the Genetic Models Match the Ancestry of Patient Populations
Dec 07, 2025
When a Child Is Treated for ALL, a Family’s Financial Pain Unfolds Over Time, Study Finds
Dec 06, 2025
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
Dec 06, 2025
Advertisement
Shorts
1:32
Getting Lenacapavir on Insurance Plans Is Key to Uptake: Antonio Urbina, MD
5 days ago
by
Julia Bonavitacola(+1 more)
1:52
DTC Models Offer Promise for Some, but Remain Limited in Scope: Brian Reid, MS
5 days ago
by
Brooke McCormick(+1 more)
0:53
Treatments for Symptom-Driven Conditions Are the Best Fit for DTC Models: Jennifer Graff, PharmD
6 days ago
by
Brooke McCormick(+1 more)
0:37
Oral Pill Removes Barrier to Cholesterol-Lowering Therapy: Ann Marie Navar, MD, PhD
9 days ago
by
Laura Joszt, MA(+1 more)
1:09
Administrative Glitches Could Leave Gaps in Care After Medicaid Work Requirements: Ciara Zachary, PhD, MPH
11 days ago
by
Julia Bonavitacola(+1 more)
1:02
Millions Set to Lose Medicaid Despite Some Exceptions to Work Requirements: William Schpero, PhD, MPhil, MPH
12 days ago
by
Julia Bonavitacola(+1 more)
1:16
Medicaid Work Requirements Will Have Ripple Effects on Health Care Funding: Ciara Zachary, PhD, MPH
15 days ago
by
Julia Bonavitacola(+1 more)
0:26
Vtama Shows Strong Efficacy and Safety Even in Patients With Comorbidities: Druhan Howell, MD
17 days ago
by
Sabrina McCrear(+1 more)
1:17
Work Requirements, Expiration of Subsidies Will Leave Millions Without Insurance: William Schpero, PhD, MPhil, MPH
17 days ago
by
Julia Bonavitacola
2:25
Holistic Care Coordination Should Take Priority Over Lower Drug Prices: Joey Mattingly, PharmD, PhD, MBA
17 days ago
by
Brooke McCormick(+1 more)
The Most Favored Nation Mandate Webinar Series
Join us on November 4th at 7:00PM EST for the third installment of a 3-part webinar series exploring the policy, legal, and payer dynamics of MFN.
Center on Health Equity & Access
Start seeing what truly shapes access and learn how you can redefine the landscape.
Podcasts
Center on Health Equity & Access
Continuing Medical Education
Advertisement
All News
Advertisement
A phase 2 trial demonstrated substantial weight loss with the long-acting peptide–antibody conjugate, as well as other cardiometabolic improvements.
Rusfertide shows promise in maintaining hematocrit control and improving quality of life for polycythemia vera patients, reducing phlebotomy needs significantly.
Experts at an Institute for Value-Based Medicine event held October 14, 2025, in Aurora, Colorado, explored advances in neurology care, cross-specialty collaboration, and strategies to improve access and therapy.
Quality improvement programs markedly increase sleep apnea testing in stroke patients, showing effective ways to improve guideline-based care.
Public health dental hygienists expand dental care access and oral health education in underserved communities, improving overall health outcomes.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Hereditary ovarian cancer genes occur across diverse populations, supporting inclusive genetic testing.
Minimally invasive thymectomy for ocular myasthenia gravis (MG) enhanced complete stable remission rates and reduced surgical risks.
Experts met in Park City, Utah, on October 7, 2025, to discuss how new technologies can help address chronic kidney disease.
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma
3
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
4
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
5
